title: Two medical therapies very effective shortly after high levels of soman poisoning in rats, but only one with universal utility.
abstract: A treatment regimen consisting of HI-6, scopolamine, and physostigmine (termed the physostigmine regimen) has been based on the serendipitous discovery that it exerts powerful antidotal effects against high levels of soman poisoning if it is administered 1 min after exposure. A medical therapy with corresponding efficacy, but without the time limitation of the latter regimen, has been developed through studies of microinfusions of anticonvulsants into seizure controlling sites in the forebrain of rats. From these studies procyclidine emerged as the most potent anticonvulsant, and its potency was further enhanced when being combined with the antiepileptic levetiracetam during systemic administration. In the present study, the capacity of HI-6, levetiracetam, and procyclidine (termed the procyclidine regimen) was tested against that of the physostigmine regimen. The results showed that both regimens were very effective against supralethal doses of soman (3, 4, 5 × LD₅₀) when given 1 and 5 min after intoxication. When the treatments were administered 10 and 14 or 20 and 24 min after soman exposure, only the procyclidine regimen was able to terminate seizures and preserve lives. When used as prophylactic therapies, both regimens protected equally well against seizures, but only the procyclidine regimen provided neuroprotection. The procyclidine regimen has apparently capacities to serve as a universal therapy against soman intoxication in rats.
authors: Norwegian Defence Research Establishment (FFI), Protection Division, P.O. Box 25, NO-2027 Kjeller, Norway. Electronic address: trond.myhrer@ffi.no.
authors: Trond
authors: T
authors: Myhrer
authors: Siri
authors: S
authors: Enger
authors: Espen
authors: E
authors: Mariussen
authors: Pål
authors: P
authors: Aas
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010830:Physostigmine / Q000627:therapeutic use*; D011352:Procyclidine / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D012640:Seizures / Q000139:chemically induced* / Q000517:prevention & control*; D012999:Soman / Q000506:poisoning*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D018696:Neuroprotective Agents; D012999:Soman; D010830:Physostigmine; D011352:Procyclidine
keywords: HI-6; Levetiracetam; Physostigmine; Procyclidine; Scopolamine; Soman intoxication